LONDON, UK: IP Group plc (LSE: IPO) portfolio company Microbiotica Ltd, a leading player in discovering and developing microbiome-based therapeutics and biomarkers, has completed its £50m Series B financing round, the largest microbiome-related financing in Europe to date. The financing round was also supported by new investors Flerie Invest, Tencent and British Patient Capital as well as existing investors…